Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24


An observational study of self-reported sedentary behaviour in people with chronic obstructive pulmonary disease and bronchiectasis.

McKeough ZJ, Large SL, Spencer LM, Cheng SWM, McNamara RJ.

Braz J Phys Ther. 2019 Jun 5. pii: S1413-3555(19)30069-3. doi: 10.1016/j.bjpt.2019.05.005. [Epub ahead of print]


Associations of Diet and Physical Activity with Risk for Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Mijatovic-Vukas J, Capling L, Cheng S, Stamatakis E, Louie J, Cheung NW, Markovic T, Ross G, Senior A, Brand-Miller JC, Flood VM.

Nutrients. 2018 May 30;10(6). pii: E698. doi: 10.3390/nu10060698. Review.


Low leisure-based sitting time and being physically active were associated with reduced odds of death and diabetes in people with chronic obstructive pulmonary disease: a cohort study.

McKeough Z, Cheng SWM, Alison J, Jenkins C, Hamer M, Stamatakis E.

J Physiother. 2018 Apr;64(2):114-120. doi: 10.1016/j.jphys.2018.02.007. Epub 2018 Mar 21.


Associations of total and type-specific physical activity with mortality in chronic obstructive pulmonary disease: a population-based cohort study.

Cheng SWM, McKeough Z, Alison J, Dennis S, Hamer M, Stamatakis E.

BMC Public Health. 2018 Feb 17;18(1):268. doi: 10.1186/s12889-018-5167-5.


Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications.

Ezzat S, Cheng S, Asa SL.

Mol Cell Endocrinol. 2018 Jul 5;469:70-76. doi: 10.1016/j.mce.2017.07.011. Epub 2017 Jul 12. Review.


A behaviour change intervention to reduce sedentary time in people with chronic obstructive pulmonary disease: protocol for a randomised controlled trial.

Cheng SWM, Alison J, Dennis S, Stamatakis E, Spencer L, McNamara R, Sims S, McKeough Z.

J Physiother. 2017 Jul;63(3):182. doi: 10.1016/j.jphys.2017.04.001. Epub 2017 May 16.


Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Shi X, Liu R, Basolo F, Giannini R, Shen X, Teng D, Guan H, Shan Z, Teng W, Musholt TJ, Al-Kuraya K, Fugazzola L, Colombo C, Kebebew E, Jarzab B, Czarniecka A, Bendlova B, Sykorova V, Sobrinho-Simões M, Soares P, Shong YK, Kim TY, Cheng S, Asa SL, Viola D, Elisei R, Yip L, Mian C, Vianello F, Wang Y, Zhao S, Oler G, Cerutti JM, Puxeddu E, Qu S, Wei Q, Xu H, O'Neill CJ, Sywak MS, Clifton-Bligh R, Lam AK, Riesco-Eizaguirre G, Santisteban P, Yu H, Tallini G, Holt EH, Vasko V, Xing M.

J Clin Endocrinol Metab. 2016 Jan;101(1):264-74. doi: 10.1210/jc.2015-2917. Epub 2015 Nov 3.


The role of diabetes in acromegaly associated neoplasia.

Cheng S, Gomez K, Serri O, Chik C, Ezzat S.

PLoS One. 2015 May 21;10(5):e0127276. doi: 10.1371/journal.pone.0127276. eCollection 2015.


Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide.

Gonzalez B, Vargas G, Ramirez C, Asa S, Cheng S, Sandoval C, Mercado M.

Endocrinol Nutr. 2014 Dec;61(10):523-30. doi: 10.1016/j.endonu.2014.05.006. Epub 2014 Jul 5. English, Spanish.


Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.

Morin E, Cheng S, Mete O, Serra S, Araujo PB, Temple S, Cleary S, Gallinger S, Greig PD, McGilvray I, Wei A, Asa SL, Ezzat S.

Cancer Med. 2013 Oct;2(5):701-11. doi: 10.1002/cam4.96. Epub 2013 Aug 6.


Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.

Cheng S, Al-Agha R, Araujo PB, Serri O, L Asa S, Ezzat S.

PLoS One. 2013 Sep 9;8(9):e73543. doi: 10.1371/journal.pone.0073543. eCollection 2013.


Evaluation of the WHO 2010 grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumors.

Araujo PB, Cheng S, Mete O, Serra S, Morin E, Asa SL, Ezzat S.

PLoS One. 2013 Apr 19;8(4):e61538. doi: 10.1371/journal.pone.0061538. Print 2013.


Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.

Ramírez C, Cheng S, Vargas G, Asa SL, Ezzat S, González B, Cabrera L, Guinto G, Mercado M.

J Clin Endocrinol Metab. 2012 May;97(5):1745-51. doi: 10.1210/jc.2011-3163. Epub 2012 Mar 14.


Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature.

Cheng S, Grasso L, Martinez-Orozco JA, Al-Agha R, Pivonello R, Colao A, Ezzat S.

Clin Endocrinol (Oxf). 2012 Feb;76(2):264-71. doi: 10.1111/j.1365-2265.2011.04180.x. Review.


A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior.

Cheng S, Serra S, Mercado M, Ezzat S, Asa SL.

Clin Cancer Res. 2011 Apr 15;17(8):2385-94. doi: 10.1158/1078-0432.CCR-10-2837. Epub 2011 Mar 9.


Osteopontin (OPN) expression in thyroid carcinoma.

Briese J, Cheng S, Ezzat S, Liu W, Winer D, Wagener C, Bamberger AM, Asa SL.

Anticancer Res. 2010 May;30(5):1681-8.


Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation.

Simpson CD, Mawji IA, Anyiwe K, Williams MA, Wang X, Venugopal AL, Gronda M, Hurren R, Cheng S, Serra S, Beheshti Zavareh R, Datti A, Wrana JL, Ezzat S, Schimmer AD.

Cancer Res. 2009 Apr 1;69(7):2739-47. doi: 10.1158/0008-5472.CAN-08-2530. Epub 2009 Mar 17.


Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.

Cheng S, Liu W, Mercado M, Ezzat S, Asa SL.

Endocr Relat Cancer. 2009 Jun;16(2):455-66. doi: 10.1677/ERC-09-0002. Epub 2009 Mar 4.


The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.

Liu W, Cheng S, Asa SL, Ezzat S.

Cancer Res. 2008 Oct 1;68(19):8104-12. doi: 10.1158/0008-5472.CAN-08-2132.


[Macroprolactinemia identification in patients with hyperprolactinemia].

Sandoval C, González B, Cheng S, Esquenazi Y, Mercado M.

Ginecol Obstet Mex. 2007 Aug;75(8):459-64. Spanish.


Supplemental Content

Loading ...
Support Center